10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

XRTX (Xortx) Stock Analysis
Buy, Hold or Sell?

Let's analyze Xortx together

I guess you are interested in XORTX Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Xortx’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Xortx’s Price Targets

I'm going to help you getting a better view of XORTX Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about XORTX Therapeutics Inc

I send you an email if I find something interesting about XORTX Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Xortx (30 sec.)










1.2. What can you expect buying and holding a share of Xortx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.72
Expected worth in 1 year
$0.79
How sure are you?
21.6%

+ What do you gain per year?

Total Gains per Share
$0.07
Return On Investment
6.6%

For what price can you sell your share?

Current Price per Share
$1.00
Expected price per share
$0.802 - $1.09
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Xortx (5 min.)




Live pricePrice per Share (EOD)
$1.00
Intrinsic Value Per Share
$17.93 - $22.37
Total Value Per Share
$18.66 - $23.10

2.2. Growth of Xortx (5 min.)




Is Xortx growing?

Current yearPrevious yearGrowGrow %
How rich?$2.7m$5.1m-$2.4m-88.9%

How much money is Xortx making?

Current yearPrevious yearGrowGrow %
Making money-$249.1k-$836.2k$587.1k235.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Xortx (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#692 / 884

Most Revenue
#868 / 884

Most Profit
#191 / 884

Most Efficient
#183 / 884
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Xortx?

Welcome investor! Xortx's management wants to use your money to grow the business. In return you get a share of Xortx.

First you should know what it really means to hold a share of Xortx. And how you can make/lose money.

Speculation

The Price per Share of Xortx is $1. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Xortx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Xortx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.72. Based on the TTM, the Book Value Change Per Share is $0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Xortx.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.18-18.4%-0.07-6.6%-0.22-22.1%-0.27-26.9%-0.25-24.5%-0.17-16.8%
Usd Book Value Change Per Share-0.16-15.7%0.021.7%-0.43-43.3%-0.23-23.4%0.010.7%0.021.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.16-15.7%0.021.7%-0.43-43.3%-0.23-23.4%0.010.7%0.021.9%
Usd Price Per Share0.96-1.41-1.81-1.40-1.58-0.90-
Price to Earnings Ratio-1.30-3.90--0.28-1.03--0.11--0.27-
Price-to-Total Gains Ratio-6.13-5.06--3.95--0.83--4.43--5.43-
Price to Book Ratio1.33-2.05-2.05-1.48-1.24--0.06-
Price-to-Total Gains Ratio-6.13-5.06--3.95--0.83--4.43--5.43-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1
Number of shares1000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.020.01
Usd Total Gains Per Share0.020.01
Gains per Quarter (1000 shares)16.517.29
Gains per Year (1000 shares)66.0529.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10665602919
2013212205848
3019818808877
402642540117106
503303200146135
603963860175164
704624520204193
805285180233222
905945840263251
1006606500292280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%3.09.00.025.0%4.016.00.020.0%5.032.00.013.5%5.034.00.012.8%
Book Value Change Per Share2.02.00.050.0%2.010.00.016.7%4.016.00.020.0%8.029.00.021.6%9.030.00.023.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.037.00.0%0.00.039.00.0%
Total Gains per Share2.02.00.050.0%2.010.00.016.7%4.016.00.020.0%8.029.00.021.6%9.030.00.023.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of XORTX Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1570.017-1048%-0.433+177%-0.234+50%0.007-2247%0.019-933%
Book Value Per Share--0.7240.720+0%1.361-47%1.606-55%1.460-50%0.829-13%
Current Ratio--2.7773.537-21%13.181-79%9.043-69%7.158-61%5.637-51%
Debt To Asset Ratio--0.2160.321-33%0.219-1%0.265-18%0.374-42%0.483-55%
Debt To Equity Ratio--0.2760.521-47%0.438-37%0.448-38%0.525-47%2.118-87%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--2879370.0005962861.050-52%10168151.481-72%9245433.850-69%9217492.590-69%7105544.599-59%
Eps---0.184-0.066-64%-0.221+20%-0.269+46%-0.245+33%-0.168-9%
Free Cash Flow Per Share---0.171-0.200+17%-0.359+110%-0.436+155%-0.368+115%-0.228+34%
Free Cash Flow To Equity Per Share---0.153-0.127-17%-0.268+75%-0.241+57%0.030-604%0.021-817%
Gross Profit Margin--1.0000.155+545%1.039-4%0.731+37%0.839+19%0.914+9%
Intrinsic Value_10Y_max--22.375----------
Intrinsic Value_10Y_min--17.933----------
Intrinsic Value_1Y_max---1.169----------
Intrinsic Value_1Y_min---1.150----------
Intrinsic Value_3Y_max---0.913----------
Intrinsic Value_3Y_min---0.924----------
Intrinsic Value_5Y_max--2.478----------
Intrinsic Value_5Y_min--2.076----------
Market Cap3788250.000+4%3636720.0005331583.050-32%6874631.981-47%5297741.350-31%5992708.440-39%3397046.637+7%
Net Profit Margin----0%-0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%-0%
Pb Ratio1.382+4%1.3272.046-35%2.054-35%1.482-10%1.243+7%-0.063+105%
Pe Ratio-1.356-4%-1.3013.904-133%-0.285-78%1.033-226%-0.106-92%-0.266-80%
Price Per Share1.000+4%0.9601.407-32%1.815-47%1.398-31%1.582-39%0.897+7%
Price To Free Cash Flow Ratio-1.464-4%-1.405-1.764+26%-1.309-7%-1.174-16%-3.711+164%-2.379+69%
Price To Total Gains Ratio-6.386-4%-6.1305.063-221%-3.947-36%-0.828-87%-4.435-28%-5.432-11%
Quick Ratio--0.0232.650-99%11.969-100%8.224-100%6.203-100%4.886-100%
Return On Assets---0.200-0.072-64%-0.106-47%-0.106-47%-0.145-27%-0.205+3%
Return On Equity---0.255-0.108-58%-0.270+6%-0.191-25%-0.175-31%-0.503+98%
Total Gains Per Share---0.1570.017-1048%-0.433+177%-0.234+50%0.007-2247%0.019-933%
Usd Book Value--2741318.0002728546.000+0%5154361.000-47%6083996.167-55%5531445.450-50%3139652.459-13%
Usd Book Value Change Per Share---0.1570.017-1048%-0.433+177%-0.234+50%0.007-2247%0.019-933%
Usd Book Value Per Share--0.7240.720+0%1.361-47%1.606-55%1.460-50%0.829-13%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--2879370.0005962861.050-52%10168151.481-72%9245433.850-69%9217492.590-69%7105544.599-59%
Usd Eps---0.184-0.066-64%-0.221+20%-0.269+46%-0.245+33%-0.168-9%
Usd Free Cash Flow---647115.000-758387.500+17%-1358116.000+110%-1652033.083+155%-1392672.650+115%-865489.838+34%
Usd Free Cash Flow Per Share---0.171-0.200+17%-0.359+110%-0.436+155%-0.368+115%-0.228+34%
Usd Free Cash Flow To Equity Per Share---0.153-0.127-17%-0.268+75%-0.241+57%0.030-604%0.021-817%
Usd Market Cap3788250.000+4%3636720.0005331583.050-32%6874631.981-47%5297741.350-31%5992708.440-39%3397046.637+7%
Usd Price Per Share1.000+4%0.9601.407-32%1.815-47%1.398-31%1.582-39%0.897+7%
Usd Profit---698673.000-249135.500-64%-836241.500+20%-1019632.500+46%-928125.250+33%-637766.378-9%
Usd Revenue----0%-0%-0%-0%-0%
Usd Total Gains Per Share---0.1570.017-1048%-0.433+177%-0.234+50%0.007-2247%0.019-933%
 EOD+5 -3MRQTTM+12 -20YOY+19 -133Y+19 -135Y+11 -2110Y+12 -20

3.3 Fundamental Score

Let's check the fundamental score of XORTX Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.356
Price to Book Ratio (EOD)Between0-11.382
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.023
Current Ratio (MRQ)Greater than12.777
Debt to Asset Ratio (MRQ)Less than10.216
Debt to Equity Ratio (MRQ)Less than10.276
Return on Equity (MRQ)Greater than0.15-0.255
Return on Assets (MRQ)Greater than0.05-0.200
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of XORTX Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.050
Ma 20Greater thanMa 500.889
Ma 50Greater thanMa 1000.959
Ma 100Greater thanMa 2000.946
OpenGreater thanClose0.975
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About XORTX Therapeutics Inc

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.

Fundamental data was last updated by Penke on 2025-07-03 02:03:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Xortx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Xortx to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of XORTX Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--92.7%+92.7%
TTM--141.4%+141.4%
YOY--186.1%+186.1%
3Y--248.3%+248.3%
5Y--338.6%+338.6%
10Y--488.9%+488.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Xortx is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Xortx to theΒ Biotechnology industry mean.
  • -20.0% Return on Assets means thatΒ Xortx generatedΒ $-0.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of XORTX Therapeutics Inc:

  • The MRQ is -20.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.0%TTM-7.2%-12.8%
TTM-7.2%YOY-10.6%+3.4%
TTM-7.2%5Y-14.5%+7.3%
5Y-14.5%10Y-20.5%+6.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.0%-11.5%-8.5%
TTM-7.2%-11.6%+4.4%
YOY-10.6%-11.4%+0.8%
3Y-10.6%-11.8%+1.2%
5Y-14.5%-12.1%-2.4%
10Y-20.5%-13.8%-6.7%
4.3.1.3. Return on Equity

Shows how efficient Xortx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Xortx to theΒ Biotechnology industry mean.
  • -25.5% Return on Equity means Xortx generated $-0.25Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of XORTX Therapeutics Inc:

  • The MRQ is -25.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.5%TTM-10.8%-14.7%
TTM-10.8%YOY-27.0%+16.2%
TTM-10.8%5Y-17.5%+6.7%
5Y-17.5%10Y-50.3%+32.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.5%-13.6%-11.9%
TTM-10.8%-14.9%+4.1%
YOY-27.0%-14.4%-12.6%
3Y-19.1%-17.0%-2.1%
5Y-17.5%-17.9%+0.4%
10Y-50.3%-20.1%-30.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of XORTX Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Xortx is operatingΒ .

  • Measures how much profit Xortx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Xortx to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of XORTX Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.2%+229.2%
TTM--250.3%+250.3%
YOY--205.1%+205.1%
3Y--220.2%+220.2%
5Y--342.6%+342.6%
10Y--475.5%+475.5%
4.3.2.2. Operating Ratio

Measures how efficient Xortx is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of XORTX Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.110-2.110
TTM-2.704-2.704
YOY-3.063-3.063
3Y-3.576-3.576
5Y-4.713-4.713
10Y-6.512-6.512
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of XORTX Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Xortx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 2.78Β means the company has $2.78 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of XORTX Therapeutics Inc:

  • The MRQ is 2.777. The company is able to pay all its short-term debts. +1
  • The TTM is 3.537. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.777TTM3.537-0.760
TTM3.537YOY13.181-9.645
TTM3.5375Y7.158-3.621
5Y7.15810Y5.637+1.521
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7773.661-0.884
TTM3.5373.786-0.249
YOY13.1814.121+9.060
3Y9.0434.680+4.363
5Y7.1585.765+1.393
10Y5.6376.150-0.513
4.4.3.2. Quick Ratio

Measures if Xortx is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Xortx to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.02Β means the company can pay off $0.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of XORTX Therapeutics Inc:

  • The MRQ is 0.023. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 2.650. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.023TTM2.650-2.628
TTM2.650YOY11.969-9.318
TTM2.6505Y6.203-3.553
5Y6.20310Y4.886+1.317
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0232.826-2.803
TTM2.6503.128-0.478
YOY11.9693.782+8.187
3Y8.2244.304+3.920
5Y6.2035.703+0.500
10Y4.8866.454-1.568
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of XORTX Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of XortxΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Xortx to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.22Β means that Xortx assets areΒ financed with 21.6% credit (debt) and the remaining percentage (100% - 21.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of XORTX Therapeutics Inc:

  • The MRQ is 0.216. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.321. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.216TTM0.321-0.105
TTM0.321YOY0.219+0.102
TTM0.3215Y0.374-0.053
5Y0.37410Y0.483-0.109
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2160.324-0.108
TTM0.3210.347-0.026
YOY0.2190.327-0.108
3Y0.2650.339-0.074
5Y0.3740.349+0.025
10Y0.4830.382+0.101
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Xortx is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Xortx to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 27.6% means that company has $0.28 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of XORTX Therapeutics Inc:

  • The MRQ is 0.276. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.521. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.276TTM0.521-0.244
TTM0.521YOY0.438+0.083
TTM0.5215Y0.525-0.005
5Y0.52510Y2.118-1.593
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2760.383-0.107
TTM0.5210.436+0.085
YOY0.4380.410+0.028
3Y0.4480.446+0.002
5Y0.5250.460+0.065
10Y2.1180.509+1.609
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Xortx generates.

  • Above 15 is considered overpriced butΒ always compareΒ Xortx to theΒ Biotechnology industry mean.
  • A PE ratio of -1.30 means the investor is paying $-1.30Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of XORTX Therapeutics Inc:

  • The EOD is -1.356. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.301. Based on the earnings, the company is expensive. -2
  • The TTM is 3.904. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-1.356MRQ-1.301-0.054
MRQ-1.301TTM3.904-5.206
TTM3.904YOY-0.285+4.189
TTM3.9045Y-0.106+4.011
5Y-0.10610Y-0.266+0.160
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.356-2.197+0.841
MRQ-1.301-2.027+0.726
TTM3.904-2.527+6.431
YOY-0.285-3.733+3.448
3Y1.033-3.717+4.750
5Y-0.106-6.036+5.930
10Y-0.266-6.649+6.383
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of XORTX Therapeutics Inc:

  • The EOD is -1.464. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.405. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.764. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.464MRQ-1.405-0.059
MRQ-1.405TTM-1.764+0.360
TTM-1.764YOY-1.309-0.456
TTM-1.7645Y-3.711+1.947
5Y-3.71110Y-2.379-1.333
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.464-3.007+1.543
MRQ-1.405-2.704+1.299
TTM-1.764-3.627+1.863
YOY-1.309-4.334+3.025
3Y-1.174-5.070+3.896
5Y-3.711-8.532+4.821
10Y-2.379-9.305+6.926
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Xortx is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 1.33 means the investor is paying $1.33Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of XORTX Therapeutics Inc:

  • The EOD is 1.382. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.327. Based on the equity, the company is underpriced. +1
  • The TTM is 2.046. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.382MRQ1.327+0.055
MRQ1.327TTM2.046-0.719
TTM2.046YOY2.054-0.009
TTM2.0465Y1.243+0.803
5Y1.24310Y-0.063+1.306
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.3821.921-0.539
MRQ1.3271.843-0.516
TTM2.0462.113-0.067
YOY2.0542.467-0.413
3Y1.4822.541-1.059
5Y1.2433.666-2.423
10Y-0.0634.311-4.374
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of XORTX Therapeutics Inc.

4.8.1. Institutions holding XORTX Therapeutics Inc

Institutions are holding 4.711% of the shares of XORTX Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Hartland & Co0.0073027700
2025-03-31Royal Bank of Canada000-1493-100
2024-12-31Tower Research Capital LLC000-84-100
2024-12-31JPMorgan Chase & Co000-508-100
2025-03-31Armistice Capital, LLC000-265000-100
2025-03-31Advisor Group Holdings, Inc.000-1153-100
2025-03-31UBS Group AG000-17428-100
Total 0.00730277-285666-103,128.5%
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets3,499
Total Liabilities757
Total Stockholder Equity2,741
 As reported
Total Liabilities 757
Total Stockholder Equity+ 2,741
Total Assets = 3,499

Assets

Total Assets3,499
Total Current Assets2,103
Long-term Assets1,395
Total Current Assets
Cash And Cash Equivalents 1,895
Net Receivables 17
Total Current Assets  (as reported)2,103
Total Current Assets  (calculated)1,912
+/- 191
Long-term Assets
Property Plant Equipment 15
Intangible Assets 180
Long-term Assets  (as reported)1,395
Long-term Assets  (calculated)195
+/- 1,200

Liabilities & Shareholders' Equity

Total Current Liabilities757
Long-term Liabilities0
Total Stockholder Equity2,741
Total Current Liabilities
Accounts payable 354
Other Current Liabilities 326
Total Current Liabilities  (as reported)757
Total Current Liabilities  (calculated)680
+/- 77
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)2,741
Total Stockholder Equity (calculated)0
+/- 2,741
Other
Capital Stock18,913
Common Stock Shares Outstanding 3,788
Net Invested Capital 2,741
Net Working Capital 1,346
Property Plant and Equipment Gross 235



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
> Total Assets 
0
0
0
180
192
191
316
276
244
238
457
191
139
424
491
1,820
1,577
1,357
1,265
1,128
1,087
1,076
1,088
3,359
2,875
2,664
2,290
8,248
7,333
7,833
22,036
18,441
16,045
14,961
16,753
9,659
7,801
6,640
5,468
6,051
4,799
3,850
4,092
3,499
3,4994,0923,8504,7996,0515,4686,6407,8019,65916,75314,96116,04518,44122,0367,8337,3338,2482,2902,6642,8753,3591,0881,0761,0871,1281,2651,3571,5771,820491424139191457238244276316191192180000
   > Total Current Assets 
0
0
0
11
21
16
79
39
7
1
226
186
134
100
64
1,533
1,294
1,070
980
847
808
799
815
3,088
2,606
2,396
2,056
8,018
7,097
7,589
20,173
16,580
14,014
12,951
14,750
8,213
6,378
5,226
4,069
4,662
3,357
2,410
2,675
2,103
2,1032,6752,4103,3574,6624,0695,2266,3788,21314,75012,95114,01416,58020,1737,5897,0978,0182,0562,3962,6063,0888157998088479801,0701,2941,53364100134186226173979162111000
       Cash And Cash Equivalents 
0
0
0
1
9
1
73
37
7
1
224
186
134
98
62
872
596
388
260
143
99
108
59
511
313
189
171
6,044
5,149
4,998
18,851
15,509
13,421
12,160
14,126
7,908
6,164
5,069
3,448
3,835
3,078
2,301
2,472
1,895
1,8952,4722,3013,0783,8353,4485,0696,1647,90814,12612,16013,42115,50918,8514,9985,1496,04417118931351159108991432603885968726298134186224173773191000
       Net Receivables 
0
0
0
10
2
4
2
2
0
0
0
0
0
0
0
0
0
28
30
29
47
21
15
22
28
16
14
-3,653
1,491
1,848
52
156
249
87
82
36
30
68
61
31
23
13
18
17
1718132331616830368287249156521,8481,491-3,65314162822152147293028000000000224210000
       Other Current Assets 
0
0
0
0
8
8
2
0
0
0
2
0
0
2
2
661
698
0
720
705
709
690
757
2,577
2,292
2,206
1,885
1,974
1,949
2,591
2,037
915
344
89
380
269
184
89
312
796
255
97
185
0
01859725579631289184269380893449152,0372,5911,9491,9741,8852,2062,2922,5777576907097057200698661220020002880000
   > Long-term Assets 
0
0
0
169
171
176
237
237
237
237
231
5
5
324
427
287
283
287
286
281
279
278
273
271
269
269
234
230
236
244
1,863
1,861
2,032
2,010
2,003
1,445
1,423
1,414
1,399
1,388
1,443
1,440
1,417
1,395
1,3951,4171,4401,4431,3881,3991,4141,4231,4452,0032,0102,0321,8611,86324423623023426926927127327827928128628728328742732455231237237237237176171169000
       Property Plant Equipment 
0
0
0
169
171
176
237
237
237
237
231
5
5
0
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
167
143
126
77
61
42
24
22
74
54
35
15
153554742224426177126143167000000000001111111055231237237237237176171169000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
258
259
286
282
286
285
280
278
277
272
271
269
269
234
230
236
244
256
255
259
260
271
168
162
172
175
166
169
186
183
180
1801831861691661751721621682712602592552562442362302342692692712722772782802852862822862592580000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,606
1,606
1,606
1,606
1,606
0
0
0
0
0
-49
0
0
0
000-49000001,6061,6061,6061,6061,606000000000000000000000000000000
> Total Liabilities 
0
0
0
60
86
132
8
8
21
67
9
14
9
855
1,145
822
829
897
944
966
1,066
1,177
1,300
1,170
871
995
1,034
4,777
4,013
12,072
5,298
5,041
3,801
4,254
7,286
600
403
554
826
3,559
2,095
1,717
758
757
7577581,7172,0953,5598265544036007,2864,2543,8015,0415,29812,0724,0134,7771,0349958711,1701,3001,1771,0669669448978298221,14585591496721881328660000
   > Total Current Liabilities 
0
0
0
60
86
132
8
8
21
67
9
14
9
855
1,109
822
829
897
900
921
1,019
1,128
1,300
1,170
871
995
1,034
4,777
4,013
12,072
5,298
856
995
1,944
2,050
600
403
554
295
341
522
1,717
758
757
7577581,7175223412955544036002,0501,9449958565,29812,0724,0134,7771,0349958711,1701,3001,1281,0199219008978298221,10985591496721881328660000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
229
188
38
40
41
0
0
0
0
51
53
0
0
0
0
0
0
0
0
67
152
66
62
45
29
12
14
84
61
39
0
03961841412294562661526700000000535100004140381882290000000000000
       Accounts payable 
0
0
0
28
41
69
6
6
16
51
7
0
7
128
331
255
262
311
304
303
362
399
465
358
203
267
306
21
290
503
324
587
577
972
1,294
421
238
394
196
185
270
111
84
354
354841112701851963942384211,29497257758732450329021306267203358465399362303304311262255331128707511666694128000
       Other Current Liabilities 
0
0
0
20
29
31
0
0
0
0
0
14
0
331
590
529
526
545
596
617
657
729
784
760
668
727
728
4,756
3,724
11,569
377
99
351
820
690
117
121
131
88
142
168
1,545
719
326
3267191,545168142881311211176908203519937711,5693,7244,75672872766876078472965761759654552652959033101400000312920000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36
0
0
0
43
45
47
49
0
0
0
0
0
0
0
0
4,597
4,185
2,806
2,310
5,236
5,236
0
0
531
3,219
1,573
0
0
0
0001,5733,219531005,2365,2362,3102,8064,1854,59700000000494745430003600000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,597
4,185
2,745
2,272
5,221
0
0
0
0
0
0
0
0
0
0000000005,2212,2722,7454,1854,597000000000000000000000000000000
> Total Stockholder Equity
0
0
0
120
106
59
308
267
223
171
448
177
130
-430
-655
998
748
460
322
162
21
-101
-212
2,189
2,004
1,670
1,256
3,471
3,320
-4,239
16,738
13,401
12,244
10,707
9,466
9,059
7,398
6,086
4,642
2,491
2,705
2,134
3,335
2,741
2,7413,3352,1342,7052,4914,6426,0867,3989,0599,46610,70712,24413,40116,738-4,2393,3203,4711,2561,6702,0042,189-212-10121162322460748998-655-43013017744817122326730859106120000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,864
5,864
5,864
5,864
5,864
8,350
8,350
8,350
8,258
12,278
12,255
13,057
20,009
20,009
20,009
20,009
20,607
17,057
17,057
17,057
17,057
17,871
17,871
17,843
18,483
0
018,48317,84317,87117,87117,05717,05717,05717,05720,60720,00920,00920,00920,00913,05712,25512,2788,2588,3508,3508,3505,8645,8645,8645,8645,864000000000000000000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
273
297
529
554
573
581
575
0
0
0
0
0
0
0
1,404
1,495
1,489
6,419
6,505
6,930
6,955
8,035
-53
-53
-53
-53
-53
-53
-53
6,008
0
06,008-53-53-53-53-53-53-538,0356,9556,9306,5056,4191,4891,4951,40400000005755815735545292972730000000000000
   Capital Surplus 00000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
510
468
567
703
886
679
845
1,220
1,220
1,220
1,397
-187
5,869
5,869
5,869
5
5
594
604
683
631
-537
0
1,036
1,404
1,495
1,489
6,419
6,505
-2,742
-2,878
8,035
9,584
9,615
9,637
5,493
5,546
5,590
5,634
0
0
005,6345,5905,5465,4939,6379,6159,5848,035-2,878-2,7426,5056,4191,4891,4951,4041,0360-537631683604594555,8695,8695,869-1871,3971,2201,2201,220845679886703567468510000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-4,118
Operating Income-4,118-4,118
 
Operating Expense (+$)
Research Development184
Selling General Administrative2,284
Selling And Marketing Expenses-
Operating Expense4,1182,468
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-122
Net Interest Income122
 
Pretax Income (+$)
Operating Income-4,118
Net Interest Income122
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-3,313-4,801
EBIT - interestExpense = 0
-3,313
-3,313
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--3,313
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-3,313
Tax Provision--
Net Income From Continuing Ops-3,313-3,313
Net Income-3,313
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net683-122
 

Technical Analysis of Xortx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Xortx. The general trend of Xortx is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Xortx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Xortx Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of XORTX Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.06 < 1.09 < 1.09.

The bearish price targets are: 0.802 > 0.802.

Know someone who trades $XRTX? Share this with them.πŸ‘‡

XORTX Therapeutics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of XORTX Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

XORTX Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of XORTX Therapeutics Inc. The current macd is -0.00763408.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Xortx price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Xortx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Xortx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
XORTX Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartXORTX Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of XORTX Therapeutics Inc. The current adx is 18.20.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Xortx shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
XORTX Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of XORTX Therapeutics Inc. The current sar is 0.81246782.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
XORTX Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of XORTX Therapeutics Inc. The current rsi is 60.05. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
XORTX Therapeutics Inc Daily Relative Strength Index (RSI) ChartXORTX Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of XORTX Therapeutics Inc. The current phase is Overbought in neutral market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Xortx price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
XORTX Therapeutics Inc Daily Stochastic Oscillator ChartXORTX Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of XORTX Therapeutics Inc. The current cci is 194.32.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
XORTX Therapeutics Inc Daily Commodity Channel Index (CCI) ChartXORTX Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of XORTX Therapeutics Inc. The current cmo is 32.29.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
XORTX Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartXORTX Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of XORTX Therapeutics Inc. The current willr is -13.15789474.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
XORTX Therapeutics Inc Daily Williams %R ChartXORTX Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of XORTX Therapeutics Inc.

XORTX Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of XORTX Therapeutics Inc. The current atr is 0.06552625.

XORTX Therapeutics Inc Daily Average True Range (ATR) ChartXORTX Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of XORTX Therapeutics Inc. The current obv is 190,611,093.

XORTX Therapeutics Inc Daily On-Balance Volume (OBV) ChartXORTX Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of XORTX Therapeutics Inc. The current mfi is 79.27.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
XORTX Therapeutics Inc Daily Money Flow Index (MFI) ChartXORTX Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for XORTX Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

XORTX Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of XORTX Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.050
Ma 20Greater thanMa 500.889
Ma 50Greater thanMa 1000.959
Ma 100Greater thanMa 2000.946
OpenGreater thanClose0.975
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Xortx with someone you think should read this too:
  • Are you bullish or bearish on Xortx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Xortx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about XORTX Therapeutics Inc

I send you an email if I find something interesting about XORTX Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about XORTX Therapeutics Inc.

Receive notifications about XORTX Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.